Search Results 861-870 of 18382 for prostate cancer
Clinical Trials · Understanding The Resistance To Enzalutamide In Patients With Castrate Resistant Metastatic Prostate Cancer · More about research at Mayo Clinic.
Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. ... prostate cancer. The study aims to assess whether the drug is safe ...
2009 European Randomized Study of Screening for Prostate Cancer and Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial; 2013 American Urological ...
Prostate cancer is the most common cancer in men, yet screening with prostatic-specific antigens is less than optimal. New and improved testing is needed ...
However, cancer is just one of several possible causes of increased prostate-specific antigen levels. After any procedure for an enlarged prostate, a number of ...
For ovarian cancer, fallopian tube cancer, pancreas cancer, primary peritoneal cancer, prostate cancer, or metastatic breast cancer: Adults—300 milligrams (mg) ...
Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes. Prostate Cancer Prostatic Dis. 2025 Mar; 28(1):129-137. Epub 2024 Feb 28 ...
... prostate cancer. The objectives are to describe the practice patterns of therapeutic agents for treatment of advanced prostate cancer internationally; to ...
"I knew I had a family history of prostate cancer," Michael says. "When Dr. Price was giving me my options, I asked him what would happen if I did nothing? And ...
Prostate cancer screening. September is National Prostate Cancer Awareness Month. Cancer screening tests, including the prostate-specific antigen (PSA) test ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.